Cover storyFDA’s Proposed DTC Rule Could End TV Drug Ads
FDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.
Cover storyFDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.

FDA lab analysis confirms RX7 Articulaciones contains undeclared diclofenac and dexamethasone, raising supply-chain and labeling compliance concerns.

FDA lab analysis confirms Ort-Flx contains undeclared diclofenac, dexamethasone, and methocarbamol, triggering MedWatch reporting obligations.

Azora Therapeutics rebrands from Adial Pharmaceuticals and names new leadership as AT177 Phase 1 targets H1 2027.
FDA has cleared 30-plus biosimilars since mid-2024, spanning denosumab, ranibizumab, insulin aspart, and oncology biologics.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Oct 28
Nov 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

